![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Themis Medicare Ltd. Vapi In, based in India, is a pharmaceutical company that stands out with its certifications from WHO-GMP.
One of their significant offerings is Propofol, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2004-218 - Rev 00
This Chemical Type CEP, issued on October 13, 2005, remains in force until December 18, 2008, ensuring its reliability within the pharmaceutical industry.
Substance Number 1558 associated with this CEP further emphasizes